Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Irradiation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00216437
What this trial is testing

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

Who this might be right for
Cancer of Liver
James A. Haley Veterans Administration Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01850368
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Korea Cancer Center Hospital 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05286320
What this trial is testing

Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.

Who this might be right for
Unresectable Hepatocellular CarcinomaPembrolizumabLenvatinib+1 more
National Taiwan University Hospital 27
Large-scale testing (Phase 3)UnknownNCT01558895
What this trial is testing

Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites

Who this might be right for
Liver CirrhosisRefractory Ascites
First People's Hospital of Foshan 40
Not applicableUnknownNCT06061445
What this trial is testing

Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma

Who this might be right for
Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital 22
Not applicableUnknownNCT05057104
What this trial is testing

Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy

Who this might be right for
Hepatocellular Carcinoma Non-resectableConversion
Beijing 302 Hospital 320
Testing effectiveness (Phase 2)Study completedNCT01911000
What this trial is testing

Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis

Who this might be right for
Carcinoma. Hepatocellular
Samsung Medical Center 69
Not applicableStudy completedNCT01519219
What this trial is testing

Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation

Who this might be right for
Hepatic Irradiation
University of Michigan Rogel Cancer Center 208
Not applicableStudy completedNCT00994370
What this trial is testing

Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT

Who this might be right for
Liver Cancer
Rutgers, The State University of New Jersey 36
Post-approval studies (Phase 4)UnknownNCT05022628
What this trial is testing

Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis

Who this might be right for
HCCChemotherapy Effect
Anhui Provincial Hospital 30
Not applicableStudy completedNCT01519232
What this trial is testing

Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)

Who this might be right for
Hepatocellular Carcinoma
University of Michigan Rogel Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Large-scale testing (Phase 3)UnknownNCT04025437
What this trial is testing

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 214
Testing effectiveness (Phase 2)Study completedNCT03535259
What this trial is testing

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, Radiotherapy, Sorafenib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 86
Testing effectiveness (Phase 2)Study completedNCT01473004
What this trial is testing

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

Who this might be right for
Stage IV Uveal Melanoma
Thomas Jefferson University 48
Not applicableStudy completedNCT03698643
What this trial is testing

Impact of New Interventional Imaging Modality Use on Patient Radiation Exposure in Transarterial Chemoembolization

Who this might be right for
Hepatic Tumor
University Hospital, Montpellier 145
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 54
Testing effectiveness (Phase 2)UnknownNCT04169399
What this trial is testing

Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Ended earlyNCT00466856
What this trial is testing

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Head and Neck CancerIslet Cell TumorMetastatic Cancer+1 more
Vanderbilt-Ingram Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07776080
What this trial is testing

Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
HCC - Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 35
Next Page